News Expanded US Imaavy approval first ever for wAIHA The FDA has approved Johnson & Johnson's Imaavy (nipocalimab-aahu) for the treatment of warm autoimmune haemolytic anaemia (wAIHA).
Patients Deliver prevention at scale, PA Consulting’s James Davis James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
